Drug interactions: perspectives of the Canadian Drugs Directorate.
Jurima-Romet
M
M
Bureau of Drug Research, Drugs Directorate, Banting Research Center, Department of National Health, Canada, Ottawa, Ontario.
D002170:Canada; D017277:Drug Approval; D004347:Drug Interactions; D017408:Guidelines as Topic; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011358:Product Surveillance, Postmarketing; D016593:Terfenadine / Q000009:adverse effects
D004364:Pharmaceutical Preparations; D016593:Terfenadine